다른 서비스와 비교했을 때 IDX 의 PS 비율은 어느 정도인가요?

IDX은 Price-To-Sales 비율(1.4x)을 기준으로 볼 때 동종 업체의 평균(1x)과 비교했을 때 비쌉니다.

IDX 의 PS 비율은 AU Healthcare 업계의 다른 회사와 어떻게 비교됩니까?

IDX 은 Australian Healthcare 과 비교하여 Price-To-Sales 비율( 1.4 x)을 기준으로 비용이 많이 듭니다. Healthcare 업계 평균( 1.5 x).

IDX 의 PS 비율과 공정 PS 비율은 어떻게 되나요? 회사의 예상 수익 성장률, 이익 마진 및 기타 위험 요소를 고려한 예상 PS 비율입니다.

IDX 1.4 예상 공정 Price-To-Sales Price-To-Sales 비율 1.2 x).

미래 현금 흐름을 볼 때 IDX 의 공정 가격은 얼마인가요? 이 추정에는 할인된 현금흐름 모델을 사용합니다.

IDX ( A$2.9 )는 당사 추정치인 [[공정 가치]]( A$18.51 )

애널리스트의 12개월 전망은 무엇이며 컨센서스 목표가에 대한 통계적 신뢰도가 있나요?

목표주가는 현재 주가 대비 20 % 미만입니다.

Integral Diagnostics (ASX:IDX) - 주가, 뉴스 및 분석

IDX 주식 개요

의료 서비스 회사인 Integral Diagnostics Limited는 호주와 뉴질랜드의 일반의, 전문의, 관련 의료 전문가 및 환자에게 진단 영상 서비스를 제공하는 기업입니다. 자세한 내용

IDX 기본 분석
눈송이 점수
가치 평가	2/6
미래 성장	4/6
과거 실적	0/6
재무 상태	2/6
배당금	1/6

보상

공정 가치 추정치보다 낮은 84.3% 에서 거래

수익은 매년 89.25% 증가할 것으로 예상됩니다.

위험 분석

이자 지급액이 수익으로 잘 충당되지 않음

Integral Diagnostics Limited 경쟁사

Australian Clinical Labs

ASX:ACL

AU$697.5m

Capitol Health

ASX:CAJ

AU$383.8m

Healius

ASX:HLS

AU$980.3m

Healthia

ASX:HLA

AU$252.1m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Integral Diagnostics
과거 주가
현재 주가	AU$2.90
52주 최고치	AU$3.20
52주 최저치	AU$1.65
베타	0.68
11개월 변경	-8.23%
3개월 변경 사항	12.84%
1년 변경 사항	68.60%
33년 변화	-40.08%
5년 변화	-20.33%
IPO 이후 변화	58.47%

최근 뉴스 및 업데이트

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19

주주 수익률

	IDX	AU Healthcare	AU 마켓
7D	-5.8%	5.7%	0.9%
1Y	68.6%	7.1%	18.4%

수익률 대 산업: IDX 지난 1년 동안 7.1 %를 반환한 Australian Healthcare 산업을 초과했습니다.

수익률 대 시장: IDX 지난 1년 동안 18.4 %를 반환한 Australian 시장을 초과했습니다.

가격 변동성

Is IDX's price volatile compared to industry and market?
IDX volatility
IDX Average Weekly Movement	3.8%
Healthcare Industry Average Movement	4.8%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.2%

안정적인 주가: IDX 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: IDX 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1967	1,977	Ian Kadish	www.integraldiagnostics.com.au

의료 서비스 회사인 Integral Diagnostics Limited는 호주와 뉴질랜드의 일반의, 전문의, 관련 의료 전문가 및 환자에게 진단 영상 서비스를 제공하는 기업입니다. 양전자 방출 단층 촬영, 자기 공명 영상 및 기타 방사선 서비스를 제공합니다. 이 회사는 1967년에 설립되었으며 호주 멜버른에 본사를 두고 있습니다.

Integral Diagnostics Limited 기본 사항 요약

Integral Diagnostics 의 수익과 매출은 시가총액과 어떻게 비교하나요?
IDX 기본 통계
시가총액	AU$678.36m
수익(TTM)	-AU$60.70m
수익(TTM)	AU$469.70m

1.4x

P/S 비율

-11.2x

P/E 비율

IDX 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
IDX 손익 계산서(TTM)
수익	AU$469.70m
수익 비용	AU$317.80m
총 이익	AU$151.90m
기타 비용	AU$212.60m
수익	-AU$60.70m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

Feb 25, 2025

주당 순이익(EPS)	-0.26
총 마진	32.34%
순이익 마진	-12.92%
부채/자본 비율	72.8%

IDX 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

2.0%

현재 배당 수익률

-22%

지급 비율

IDX 주식 개요

보상

위험 분석

Integral Diagnostics Limited 경쟁사

ASX:ACL

AU$697.5m

ASX:CAJ

AU$383.8m

ASX:HLS

AU$980.3m

ASX:HLA

AU$252.1m

가격 내역 및 성능

최근 뉴스 및 업데이트

Integral Diagnostics Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Price target increased by 7.7% to AU$2.93

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

First half dividend of AU$0.025 announced

First half 2024 earnings: EPS misses analyst expectations

Recent updates

Integral Diagnostics Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Price target increased by 7.7% to AU$2.93

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

First half dividend of AU$0.025 announced

First half 2024 earnings: EPS misses analyst expectations

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Consensus EPS estimates fall by 12%

IDX™ Announces Appointment of Scott Paterson as Worldwide CFO

Integral Diagnostics Limited, Annual General Meeting, Nov 01, 2024

Integral Diagnostics Limited Announces Change of Company Secretary

Independent Non-Executive Director recently bought AU$258k worth of stock

Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023

Consensus EPS estimates fall by 11%

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Price target decreased by 7.5% to AU$3.05

Consensus EPS estimates fall by 10%

Investor sentiment deteriorates as stock falls 27%

Integral Diagnostics Limited Appoints Toby Hall as Director

Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023

Full year 2023 earnings: EPS misses analyst expectations

Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023

Consensus EPS estimates fall by 16%

Integral Diagnostics Limited Announces Board Changes

Investor sentiment deteriorates as stock falls 18%

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.069 (vs AU$0.051 in 1H 2022)

Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023

Now 21% undervalued after recent price drop

Integral Diagnostics Limited to Report First Half, 2023 Results on Feb 17, 2023

Integral Diagnostics Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Independent Non-Executive Director recently bought AU$114k worth of stock

Consensus forecasts updated

Now 22% undervalued after recent price drop

Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Year Ended June 30, 2022, Payable on October 5, 2022

Full year 2022 earnings released

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to AU$3.65

Integral Diagnostics Limited Announces Appointment of Andrew Fay as an Independent Non-Executive Director

Healius Reportedly Keeps Watching Brief on Integral Diagnostics

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Now 21% undervalued after recent price drop

Integral Diagnostics Limited (ASX:IDX) ) agreed to acquire Exact Radiology Pty Ltd for NZD 33.3 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Exact Radiology Pty Ltd for approximately AUD 39 million.

Now 21% undervalued

Executive Director recently bought AU$70k worth of stock

Consensus forecasts updated

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Integral Diagnostics Limited Announces the Distribution for the Six Months Ended December 31, 2021, Payable on April 4, 2022

Consensus forecasts updated

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Investor sentiment deteriorated over the past week

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued